LXRX Competitors & Alternatives

Compare Lexicon Pharmaceuticals Inc with similar stocks in the same industry

Biotechnology

LXRX

Main Stock
$2.16
Tradestie Score
57
Market Cap
$512.39M
Revenue Growth
15.7%
Analyst Upside
+74.5%

Top Competitors

227 stocks in Biotechnology
Company Price Market Cap P/E Score Action
SPRY ARS Pharmaceuticals, Inc. Common Stock
$10.28
$997.16M - 66 Compare
PRME Prime Medicine, Inc. Common Stock
$3.24
$996.55M - 61 Compare
SYRE Spyre Therapeutics, Inc. Common Stock
$97.05
$994.20M - 51 Compare
VALN Valneva SE American Depositary Shares
$5.40
$993.46M - 58 Compare
IMNM Immunome, Inc.
$19.33
$987.09M - 61 Compare
BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock
$7.50
$952.74M - 52 Compare
SANA Sana Biotechnology, Inc. Common Stock
$3.35
$951.83M - 59 Compare
MNMD Mind Medicine (MindMed) Inc. Common Shares
$15.02
$938.16M - 62 Compare
ZBIO Zenas BioPharma, Inc. Common Stock
$20.21
$931.48M - 61 Compare
RLAY Relay Therapeutics, Inc. Common Stock
$17.44
$917.23M - 59 Compare

Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)

227 stocks in this industry